Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Comment by Brouwieon Nov 12, 2015 3:03am
189 Views
Post# 24283826

RE:is 400MM peak revenue a little light??

RE:is 400MM peak revenue a little light??'' Longer-term, with peak sales of $400 million annually, and margins of 90% to 95%, the company should easily generate $300 million in EBITDA. With companies selling between 10X and 15X EBITDA, that would give Telesta a valuation of $3 billion to $4.5 billion as the company approaches peak sales.''..........'' Fair valuation long-term following FDA approval: $3 billion to $4.5 billion. Shareprice: $10.41 to $15.62.......So now twice ? glta
<< Previous
Bullboard Posts
Next >>